亚太地区皮内注射市场预测至 2028 年 - COVID-19 影响和按方法（正常尺寸针、短针和无针）、应用（结核菌素皮肤测试、过敏测试、局部美学等）和最终用户进行的区域分析（医院、诊断实验室、学术和研究机构等）
No. of Pages: 138 | Report Code: TIPRE00027984 | Category: Life Sciences
No. of Pages: 138 | Report Code: TIPRE00027984 | Category: Life Sciences
发达国家和发展中国家为市场提供重要的增长机会
<发展中经济体的卫生系统注重将各种先进的治疗、诊断和美容技术引入其服务组合，以便能够提供高效率的医疗保健设施。在发达国家，皮内装置在疫苗接种和美容手术中已得到广泛接受。在发展中国家，虽然这些设备主要用于疫苗接种、结核病诊断和美容手术，但市场目前还处于发展的初级阶段。许多发展中国家是医疗旅游的有吸引力的目的地，尤其是美容手术，因为这些手术的成本比发达国家低。发展中国家的医疗机构、医疗水疗中心和健康中心越来越多地提供一系列廉价但高质量的医疗美容手术，最终引发了对皮内注射的需求。领先的皮内注射制造商正在开发理想的设备，并与其他参与者合作，以提高现有药物和新药物的治疗效果。亚太地区预计将成为所有主要地区中皮内注射剂增长最快的市场，其中中国、日本、印度和韩国等国家是预测期内市场增长的主要贡献者。城市化的快速发展、医疗保健提供商在改善基础设施方面的投资激增、人们意识的提高以及一系列先进产品和技术的可用性不断增加，都促进了该市场的增长。
市场概览
亚太地区皮内注射剂市场分为澳大利亚、中国、印度、日本、韩国和亚太地区其他地区。该地区的市场增长归因于国际企业在中国和印度的投资不断增加、政府加大支持、CRO 服务提供商基础不断扩大以及医疗保健基础设施的进步。过去几年，中国医疗器械行业增长更快。这一增长可归因于中国的“十三五”规划优先考虑健康和创新、对技术先进的医疗设备的需求增加、老年人口显着增加以及人们慢性病的增加。此外，低成本和熟练的劳动力以及巨大的生产设施空间鼓励各个市场领导者在中国设立生产工厂。人口资料局预计，到2050年，中国将有3.66亿人年龄在65岁或以上。根据世界卫生组织《中国老龄化与健康》报告，2019年，约75%的60岁及以上人口患有非传染性疾病，例如心血管疾病、糖尿病、高血压等。中国的研发部门专注于开发通过皮内途径无痛给药的装置，特别是在涉及老年人的手术过程中提供帮助。
亚太地区皮内注射剂市场收入及预测至2028年（百万美元）
亚太地区皮内注射剂市场细分
亚太地区皮内注射市场根据方法、应用、最终用户和国家进行细分。< /p>
根据方法，市场分为普通针、短针和无针。普通尺寸针头细分市场在 2021 年占据最大市场份额。普通尺寸针头细分市场进一步细分为皮内显微注射、微针阵列和纹身设备。短针段分为皮内液体喷射注射器和弹道式皮内注射器。
从应用来看，亚太皮内注射剂市场细分为结核菌素皮试、过敏测试、当地美学等。结核菌素皮试细分市场在 2021 年占据最大的市场份额。
亚太地区皮内注射市场按最终用户划分，分为医院、诊断实验室、学术机构和研究机构等。 2021 年，医院细分市场占据最大的市场份额。
根据国家/地区，市场分为澳大利亚、中国、印度、日本、韩国和其他国家/地区亚太地区。 2021 年，中国占据市场份额主导地位。
BD;西制药服务公司；泰尔茂公司；纳米通行证； PharmaJet；伊德瓦克斯；银星全球；交叉投射；康德乐健康公司；和 Hindustan Syringes and Medical Devices Ltd 是亚太地区皮内注射市场的领先公司。
Strategic insights for Asia Pacific Intradermal Injections involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
| Report Attribute | Details |
|---|---|
| Market size in 2021 | US$ 774.05 Million |
| Market Size by 2028 | US$ 1,698.43 Million |
| Global CAGR (2021 - 2028) | 11.9% |
| Historical Data | 2019-2020 |
| Forecast period | 2022-2028 |
| Segments Covered |
By 方法
|
| Regions and Countries Covered | 亚太地区
|
| Market leaders and key company profiles |
The regional scope of Asia Pacific Intradermal Injections refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
The Asia Pacific Intradermal Injections Market is valued at US$ 774.05 Million in 2021, it is projected to reach US$ 1,698.43 Million by 2028.
As per our report Asia Pacific Intradermal Injections Market, the market size is valued at US$ 774.05 Million in 2021, projecting it to reach US$ 1,698.43 Million by 2028. This translates to a CAGR of approximately 11.9% during the forecast period.
The Asia Pacific Intradermal Injections Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Asia Pacific Intradermal Injections Market report:
The Asia Pacific Intradermal Injections Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Asia Pacific Intradermal Injections Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Asia Pacific Intradermal Injections Market value chain can benefit from the information contained in a comprehensive market report.
Office No. 1011, First floor, Farena Corporate Park, Magarpatta-Mundhwa road, Pune - 411028, Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For Asia Pacific Intradermal Injections Market
